ANASTASIA GREBECK: Open Payments
NPI 1972081164 · FAIRFAX, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,030 in 104 payments from 22 companies in 2025. Trend: 2023 $1,353 · 2024 $1,820 · 2025 $2,030
Food & beverage: $2,030
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 23 | $349 |
| Janssen Biotech, Inc. | 12 | $309 |
| Ardelyx, Inc. | 9 | $186 |
| Madrigal Pharmaceuticals | 9 | $176 |
| Phathom Pharmaceuticals, Inc. | 10 | $153 |
| QOL Medical, LLC | 9 | $145 |
| PFIZER INC. | 5 | $108 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $93 |
| GENZYME CORPORATION | 3 | $65 |
| Aimmune Therapeutics, Inc. | 2 | $53 |
Products named: TREMFYA, IBSRELA, REZDIFFRA, VOQUEZNA, Sucraid, RINVOQ, DUPIXENT, ENTYVIO.
Industry payments across VA — which companies pay providers there.
